Medtronic Aims to Push Insertion of World's Tiniest Cardiac Monitor into the Physician's Office
Thursday, May 7, 2015
Source: Fierce Medical Devices
The world's smallest cardiac monitor implant is on track to make a move into the doctor's office. Medtronic's ($MDT) aim is to further capitalize upon a hugely successful launch of its Reveal Linq that's already exceeded all expectations with a potential for drug-like blockbuster annual sales of $1 billion to $2 billion.
The company has started a study of physician office insertion, in order to build further upon its standard hospital use. Upside for Medtronic lies not only in continuing to expand Linq sales, but also in grabbing market share for follow-on products that the monitor determines that these patients need.